-
Je něco špatně v tomto záznamu ?
Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer
K. Moloney, M. Janda, M. Frumovitz, M. Leitao, NR. Abu-Rustum, E. Rossi, JL. Nicklin, M. Plante, FR. Lecuru, A. Buda, A. Mariani, Y. Leung, SE. Ferguson, R. Pareja, R. Kimmig, PSY. Tong, O. McNally, N. Chetty, K. Liu, K. Jaaback, J. Lau, SYJ. Ng,...
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, multicentrická studie
NLK
ProQuest Central
od 2018-01-01 do Před 6 měsíci
Health & Medicine (ProQuest)
od 2018-01-01 do Před 6 měsíci
PubMed
33664126
DOI
10.1136/ijgc-2020-002315
Knihovny.cz E-zdroje
- MeSH
- biopsie sentinelové lymfatické uzliny metody normy MeSH
- delfská metoda MeSH
- dospělí MeSH
- gynekologie metody MeSH
- klinické kompetence MeSH
- konsensus MeSH
- lidé středního věku MeSH
- lidé MeSH
- miniinvazivní chirurgické výkony metody MeSH
- nádory endometria chirurgie MeSH
- průzkumy a dotazníky MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
INTRODUCTION: Sentinel lymph node dissection is widely used in the staging of endometrial cancer. Variation in surgical techniques potentially impacts diagnostic accuracy and oncologic outcomes, and poses barriers to the comparison of outcomes across institutions or clinical trial sites. Standardization of surgical technique and surgical quality assessment tools are critical to the conduct of clinical trials. By identifying mandatory and prohibited steps of sentinel lymph node (SLN) dissection in endometrial cancer, the purpose of this study was to develop and validate a competency assessment tool for use in surgical quality assurance. METHODS: A Delphi methodology was applied, included 35 expert gynecological oncology surgeons from 16 countries. Interviews identified key steps and tasks which were rated mandatory, optional, or prohibited using questionnaires. Using the surgical steps for which consensus was achieved, a competency assessment tool was developed and subjected to assessments of validity and reliability. RESULTS: Seventy percent consensus agreement standardized the specific mandatory, optional, and prohibited steps of SLN dissection for endometrial cancer and informed the development of a competency assessment tool. Consensus agreement identified 21 mandatory and three prohibited steps to complete a SLN dissection. The competency assessment tool was used to rate surgical quality in three preselected videos, demonstrating clear separation in the rating of the skill level displayed with mean skills summary scores differing significantly between the three videos (F score=89.4; P<0.001). Internal consistency of the items was high (Cronbach α=0.88). CONCLUSION: Specific mandatory and prohibited steps of SLN dissection in endometrial cancer have been identified and validated based on consensus among a large number of international experts. A competency assessment tool is now available and can be used for surgeon selection in clinical trials and for ongoing, prospective quality assurance in routine clinical care.
Clinical Sciences Obstetrics and Gynaecology Lund University Faculty of Medicine Lund Sweden
Division of Gynecologic Oncology Italy Ospedale Michele e Pietro Ferrero Verduno Italy
Faculty of Medicine The University of Queensland St Lucia Queensland Australia
Gynaecologic Oncology Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy
Gynaecologic Oncology John Hunter Hospital New Lambton Heights New South Wales Australia
Gynaecologic Oncology Mater Health Services Brisbane South Brisbane Queensland Australia
Gynaecologic Oncology National University Health System Singapore
Gynaecologic Oncology Royal Brisbane and Women's Hospital Herston Queensland Australia
Gynaecological Oncology Mercy Hospital for Women Heidelberg Victoria Australia
Gynaecological Oncology Royal Brisbane and Women's Hospital Herston Queensland Australia
Gynaecological Oncology Royal Marsden NHS Foundation Trust London UK
Gynaecology Oncology Mater Misericordiae University Hospital Dublin Ireland
Gynaecology St George's University of London London UK
Gynecologic Oncology CancerCare Manitoba Winnipeg Manitoba Canada
Gynecologic Oncology Clínica De Oncología Astorga Medellín Colombia
Gynecologic Oncology Instituto Nacional de Cancerologia Bogota Colombia
Gynecologic Oncology University Health Network Toronto Ontario Canada
Gynecologic Oncology University of Manitoba Winnipeg Manitoba Canada
Gynecology and Obstetrics Charles University 1st Faculty of Medicine Praha Praha Czech Republic
Gynecology and Obstetrics General University Hospital Prague Praha Czech Republic
Gynecology and Obstetrics University of Essen Essen Germany
Gynecology Leiden University Medical Center Leiden Zuid Holland The Netherlands
Gynecology Oncology Hospital Clinico San Borja Arriaran Santiago Chile
Gynecology Oncology Hospital General San Juan de Dios Guatemala Guatemala
Gynecology Oncology Universidad de Chile Santiago de Chile Chile
Obstetrics and Gynaecology National University of Singapore Singapore
Obstetrics and Gynaecology Royal Women's Hospital Parkville Victoria Australia
Obstetrics and Gynaecology Skanes Universitetssjukhus Lund Lund Skåne Sweden
Obstetrics and Gynaecology University of Toronto Toronto Ontario Canada
School of Medicine University College Dublin Dublin Ireland
Surgery and Cancer Imperial College London London UK
Surgical Oncology Institute Curie Paris France
Victorian Comprehensive Cancer Centre University of Melbourne Parkville Victoria Australia
Women's and Children's Health Karolinska Institute Stockholm Sweden
Women's and Children's Health Karolinska University Hospital Stockholm Sweden
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22012450
- 003
- CZ-PrNML
- 005
- 20220506130524.0
- 007
- ta
- 008
- 220425s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1136/ijgc-2020-002315 $2 doi
- 035 __
- $a (PubMed)33664126
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Moloney, Kristen $u Gynaecologic Oncology, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
- 245 10
- $a Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer / $c K. Moloney, M. Janda, M. Frumovitz, M. Leitao, NR. Abu-Rustum, E. Rossi, JL. Nicklin, M. Plante, FR. Lecuru, A. Buda, A. Mariani, Y. Leung, SE. Ferguson, R. Pareja, R. Kimmig, PSY. Tong, O. McNally, N. Chetty, K. Liu, K. Jaaback, J. Lau, SYJ. Ng, H. Falconer, J. Persson, R. Land, F. Martinelli, A. Garrett, A. Altman, A. Pendlebury, D. Cibula, R. Altamirano, D. Brennan, TE. Ind, C. De Kroon, KY. Tse, G. Hanna, A. Obermair
- 520 9_
- $a INTRODUCTION: Sentinel lymph node dissection is widely used in the staging of endometrial cancer. Variation in surgical techniques potentially impacts diagnostic accuracy and oncologic outcomes, and poses barriers to the comparison of outcomes across institutions or clinical trial sites. Standardization of surgical technique and surgical quality assessment tools are critical to the conduct of clinical trials. By identifying mandatory and prohibited steps of sentinel lymph node (SLN) dissection in endometrial cancer, the purpose of this study was to develop and validate a competency assessment tool for use in surgical quality assurance. METHODS: A Delphi methodology was applied, included 35 expert gynecological oncology surgeons from 16 countries. Interviews identified key steps and tasks which were rated mandatory, optional, or prohibited using questionnaires. Using the surgical steps for which consensus was achieved, a competency assessment tool was developed and subjected to assessments of validity and reliability. RESULTS: Seventy percent consensus agreement standardized the specific mandatory, optional, and prohibited steps of SLN dissection for endometrial cancer and informed the development of a competency assessment tool. Consensus agreement identified 21 mandatory and three prohibited steps to complete a SLN dissection. The competency assessment tool was used to rate surgical quality in three preselected videos, demonstrating clear separation in the rating of the skill level displayed with mean skills summary scores differing significantly between the three videos (F score=89.4; P<0.001). Internal consistency of the items was high (Cronbach α=0.88). CONCLUSION: Specific mandatory and prohibited steps of SLN dissection in endometrial cancer have been identified and validated based on consensus among a large number of international experts. A competency assessment tool is now available and can be used for surgeon selection in clinical trials and for ongoing, prospective quality assurance in routine clinical care.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a klinické kompetence $7 D002983
- 650 _2
- $a konsensus $7 D032921
- 650 _2
- $a delfská metoda $7 D003697
- 650 _2
- $a nádory endometria $x chirurgie $7 D016889
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a gynekologie $x metody $7 D006176
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a miniinvazivní chirurgické výkony $x metody $7 D019060
- 650 _2
- $a biopsie sentinelové lymfatické uzliny $x metody $x normy $7 D021701
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Janda, Monika $u Centre for Health Services Research, The University of Queensland Faculty of Medicine, Brisbane, Queensland, Australia
- 700 1_
- $a Frumovitz, Michael $u Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA $1 https://orcid.org/0000000208102648
- 700 1_
- $a Leitao, Mario $u Gynecology Service Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
- 700 1_
- $a Abu-Rustum, Nadeem R $u Gynecology Service Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA $1 https://orcid.org/0000000196891298
- 700 1_
- $a Rossi, Emma $u Obstetrics and Gynecology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
- 700 1_
- $a Nicklin, James L $u Gynaecological Oncology, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia $u Faculty of Medicine, The University of Queensland, St Lucia, Queensland, Australia
- 700 1_
- $a Plante, Marie $u Gynecology Oncology Service, Centre Hospitalier Universitaire de Québec-Université Laval, Quebec, Quebec, Canada
- 700 1_
- $a Lecuru, Fabrice R $u Surgical Oncology, Institute Curie, Paris, France $u Surgical Oncology Department for Breast and Gynecology, Universite de Paris, Paris, Île-de-France, France
- 700 1_
- $a Buda, Alessandro $u Department of Obstetrics and Gynecology, Università degli Studi Milano-Bicocca, San Gerardo Hospital, Monza, Italy $u Division of Gynecologic Oncology Italy, Ospedale Michele e Pietro Ferrero, Verduno (CN), Italy $1 https://orcid.org/0000000270936862
- 700 1_
- $a Mariani, Andrea $u Gynecologic Surgery, Department of Obstetrics and Gynecology, Mayo Clinic Rochester, Rochester, Minnesota, USA
- 700 1_
- $a Leung, Yee $u Obstetrics and Gynaecology, The University of Western Australia Faculty of Health and Medical Sciences, Perth, Western Australia, Australia
- 700 1_
- $a Ferguson, Sarah Elizabeth $u Gynecologic Oncology, University Health Network, Toronto, Ontario, Canada $u Obstetrics and Gynaecology, University of Toronto, Toronto, Ontario, Canada
- 700 1_
- $a Pareja, Rene $u Gynecologic Oncology, Instituto Nacional de Cancerologia, Bogota, Colombia $u Gynecologic Oncology, Clínica De Oncología Astorga, Medellín, Colombia $1 https://orcid.org/0000000300930438
- 700 1_
- $a Kimmig, Rainer $u Gynecology and Obstetrics, University of Essen, Essen, Germany
- 700 1_
- $a Tong, Pearl Shuang Ye $u Gynaecologic Oncology, National University Health System, Singapore
- 700 1_
- $a McNally, Orla $u Obstetrics and Gynaecology, Royal Women's Hospital, Parkville, Victoria, Australia $u Victorian Comprehensive Cancer Centre, University of Melbourne, Parkville, Victoria, Australia
- 700 1_
- $a Chetty, Naven $u Gynaecologic Oncology, Mater Health Services Brisbane, South Brisbane, Queensland, Australia
- 700 1_
- $a Liu, Kaijiang $u Gynecology and Obstetrics, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai, China
- 700 1_
- $a Jaaback, Ken $u Gynaecologic Oncology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia
- 700 1_
- $a Lau, Julio $u Gynecology Oncology, Hospital General San Juan de Dios, Guatemala, Guatemala $u Gynecology Oncology, University of San Carlos de Guatemala Faculty of Medical Sciences, Guatemala, Guatemala
- 700 1_
- $a Ng, Soon Yau Joseph $u Obstetrics and Gynaecology, National University of Singapore, Singapore
- 700 1_
- $a Falconer, Henrik $u Women's and Children's Health, Karolinska Institute, Stockholm, Sweden $u Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden $1 https://orcid.org/0000000344279421
- 700 1_
- $a Persson, Jan $u Obstetrics and Gynaecology, Skanes Universitetssjukhus Lund, Lund, Skåne, Sweden $u Clinical Sciences, Obstetrics and Gynaecology, Lund University Faculty of Medicine, Lund, Sweden
- 700 1_
- $a Land, Russell $u Gynaecologic Oncology, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia $u Faculty of Medicine, The University of Queensland, St Lucia, Queensland, Australia
- 700 1_
- $a Martinelli, Fabio $u Gynaecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy $1 https://orcid.org/0000000248631747
- 700 1_
- $a Garrett, Andrea $u Gynaecologic Oncology, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
- 700 1_
- $a Altman, Alon $u Gynecologic Oncology, University of Manitoba, Winnipeg, Manitoba, Canada $u Gynecologic Oncology, CancerCare Manitoba, Winnipeg, Manitoba, Canada
- 700 1_
- $a Pendlebury, Adam $u Gynaecological Oncology, Mercy Hospital for Women, Heidelberg, Victoria, Australia
- 700 1_
- $a Cibula, David $u Gynecology and Obstetrics, Charles University First Faculty of Medicine, Praha, Praha, Czech Republic $u Gynecology and Obstetrics, General University Hospital in Prague, Praha, Czech Republic
- 700 1_
- $a Altamirano, Roberto $u Gynecology Oncology, Universidad de Chile, Santiago de Chile, Chile $u Gynecology Oncology, Hospital Clinico San Borja Arriaran, Santiago, Chile
- 700 1_
- $a Brennan, Donal $u Gynaecology Oncology, Mater Misericordiae University Hospital, Dublin, Ireland $u School of Medicine, University College Dublin, Dublin, Ireland
- 700 1_
- $a Ind, Thomas Edward $u Gynaecological Oncology, Royal Marsden NHS Foundation Trust, London, UK $u Gynaecology, St George's University of London, London, UK $1 https://orcid.org/000000015260199X
- 700 1_
- $a De Kroon, Cornelis $u Gynecology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands
- 700 1_
- $a Tse, Ka Yu $u Obstetrics and Gynaecology, University of Hong Kong Li Ka Shing Faculty of Medicine, Hong Kong, Hong Kong
- 700 1_
- $a Hanna, George $u Surgery and Cancer, Imperial College London, London, UK
- 700 1_
- $a Obermair, Andreas $u Center for Clinical Research, Faculty of Medicine, University of Queensland, Herston, Queensland, Australia ao@surgicalperformance.com $u Queensland Centre for Gynaecologic Cancer Research, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
- 773 0_
- $w MED00009896 $t International journal of gynecological cancer : official journal of the International Gynecological Cancer Society $x 1525-1438 $g Roč. 31, č. 5 (2021), s. 647-655
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33664126 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130516 $b ABA008
- 999 __
- $a ok $b bmc $g 1789868 $s 1163651
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 31 $c 5 $d 647-655 $e 20210304 $i 1525-1438 $m International journal of gynecological cancer $n Int J Gynecol Cancer $x MED00009896
- LZP __
- $a Pubmed-20220425
